Collectively, these findings strongly support FAP as a potential biomarker for PCa progression and prognosis and provide a foundation for the in-depth exploration of the molecular mechanisms underlying FAP’s role in PCa development, metastasis, and malignant progression. This evidence concerns the gene FAP and posterior cortical atrophy.